Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466511) titled 'Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis' on March 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Condition:
Idiopathic Scoliosis
Intervention:
Dietary Supplement: Bifidobacterium breve
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2027
Target Sample Size: 100
Countries of Recruitment:
China
To know more, vi...